Contact us

ESH Video

#ESHCLL2024 LAST DAY FOR ABSTRACT SUBMISSION: DEADLINE IS ON January 9th

3^rd Translational Research Conference

CHRONIC LYMPHOCYTIC LEUKAEMIA

March 8-10, 2024

Vienna, Austria

#ESHCLL2024

FINAL CALL TO SUBMIT YOUR ABSTRACT!
Abstract submission closes on:
January 9^th, 2024 (23:59 CET)

DON'T MISS THE OPPORTUNITY:

Abstracts are eligible to be selected for an oral or a poster presentation.

About the Conference:

The 3^rd ESH Tranlational Research Conference on CHRONIC LYMPHOCYTIC LEUKAEMIA is proposing a programme of leading-edge basic and clinical science where a panel of global experts in the field will provide numerous opportunities for formal and informal interactions to discuss the present and the future of CLL research. It is open to an international audience of biologists and clinicians, particularly welcoming those in-training.

This translational research conference will explore the most recent advances in the understanding of the pathogenesis and clinical management of the disease.  Open and spirited discussion on the most up-to-date information in the field is expected to understand how the many new biologic insights apply to the future of CLL.

CONFERENCE MAIN SCIENTIFIC TOPICS:

• CLL disease progression
• Richters syndrome
• Biomarkers: where do we stand?
• Targeting the microenvironment in CLL
• What is the best time-limited therapy
• BTK inhibitors
• Small molecule resistance
• Next generation therapies
• The future: other targets

The programme will include:
Plenary Sessions - Simultaneous Meet the Experts Sessions - Brief Oral Communications
Mentored Poster Walk - Ample time for in-depth discussion.

With the support of*:

Major Conference Partner
*******

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.